Intangibles |
3 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||
| Intangibles | 4. Intangibles As a result of the acquisition of VCN, the Company has an intangible asset, in-process research and development (“IPR&D”). The IPR&D is deemed to have indefinite lives and therefore not amortized. The following table provides the Company’s in-process R&D as of March 31, 2025.
There were no impairment charges recorded during the three months ended March 31, 2025 and 2024. |
||||||||||||||||||||||||